RT Journal Article
T1 [Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience].
T2 Impacto de la COVID-19 en el tratamiento del infarto agudo de miocardio con elevación del segmento ST. La experiencia española.
A1 Rodríguez-Leor, Oriol
A1 Cid-Álvarez, Belén
A1 Pérez de Prado, Armando
A1 Rossello, Xavier
A1 Ojeda, Soledad
A1 Serrador, Ana
A1 López-Palop, Ramón
A1 Martín-Moreiras, Javier
A1 Rumoroso, José Ramón
A1 Cequier, Ángel
A1 Ibáñez, Borja
A1 Cruz-González, Ignacio
A1 Romaguera, Rafael
A1 Moreno, Raúl
A1 en representación de los investigadores del Grupo de Trabajo sobre Código Infarto de la Asociación de Cardiología Intervencionista de la Sociedad Española de Cardiología, 
A1 Villa, Manuel
A1 Ruíz-Salmerón, Rafael
A1 Molano, Francisco
A1 Sánchez, Carlos
A1 Muñoz-García, Erika
A1 Íñigo, Luís
A1 Herrador, Juan
A1 Gómez-Menchero, Antonio
A1 Gómez-Menchero, Antonio
A1 Caballero, Juan
A1 Ojeda, Soledad
A1 Cárdenas, Mérida
A1 Gheorghe, Livia
A1 Oneto, Jesús
A1 Morales, Francisco
A1 Valencia, Félix
A1 Ruíz, José Ramón
A1 Diarte, José Antonio
A1 Avanzas, Pablo
A1 Rondán, Juan
A1 Peral, Vicente
A1 Pernasetti, Lucía Vera
A1 Hernández, Julio
A1 Bosa, Francisco
A1 Lorenzo, Pedro Luís Martín
A1 Jiménez, Francisco
A1 Hernández, José M de la Torre
A1 Jiménez-Mazuecos, Jesús
A1 Lozano, Fernando
A1 Moreu, José
A1 Novo, Enrique
A1 Robles, Javier
A1 Moreiras, Javier Martín
A1 Fernández-Vázquez, Felipe
A1 Amat-Santos, Ignacio J
A1 Gómez-Hospital, Joan Antoni
A1 García-Picart, Joan
A1 Blanco, Bruno García Del
A1 Regueiro, Ander
A1 Carrillo-Suárez, Xavier
A1 Tizón, Helena
A1 Mohandes, Mohsen
A1 Casanova, Juan
A1 Agudelo-Montañez, Víctor
A1 Muñoz, Juan Francisco
A1 Franco, Juan
A1 Del Castillo, Roberto
A1 Salinas, Pablo
A1 Elizaga, Jaime
A1 Sarnago, Fernando
A1 Jiménez-Valero, Santiago
A1 Rivero, Fernando
A1 Oteo, Juan Francisco
A1 Alegría-Barrero, Eduardo
A1 Sánchez-Recalde, Ángel
A1 Ruíz, Valeriano
A1 Pinar, Eduardo
A1 Pinar, Eduardo
A1 Planas, Ana
A1 Ledesma, Bernabé López
A1 Berenguer, Alberto
A1 Fernández-Cisnal, Agustín
A1 Aguar, Pablo
A1 Pomar, Francisco
A1 Jerez, Miguel
A1 Torres, Francisco
A1 García, Ricardo
A1 Frutos, Araceli
A1 Nodar, Juan Miguel Ruíz
A1 García, Koldobika
A1 Sáez, Roberto
A1 Torres, Alfonso
A1 Tellería, Miren
A1 Sadaba, Mario
A1 Mínguez, José Ramón López
A1 Merchán, Juan Carlos Rama
A1 Portales, Javier
A1 Trillo, Ramiro
A1 Aldama, Guillermo
A1 Fernández, Saleta
A1 Santás, Melisa
A1 Pérez, María Pilar Portero
K1 COVID-19
K1 Primary angioplasty
K1 STEMI
K1 STEMI network
AB The COVID-19 outbreak has had an unclear impact on the treatment and outcomes of patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study was to assess changes in STEMI management during the COVID-19 outbreak. Using a multicenter, nationwide, retrospective, observational registry of consecutive patients who were managed in 75 specific STEMI care centers in Spain, we compared patient and procedural characteristics and in-hospital outcomes in 2 different cohorts with 30-day follow-up according to whether the patients had been treated before or after COVID-19. Suspected STEMI patients treated in STEMI networks decreased by 27.6% and patients with confirmed STEMI fell from 1305 to 1009 (22.7%). There were no differences in reperfusion strategy (> 94% treated with primary percutaneous coronary intervention in both cohorts). Patients treated with primary percutaneous coronary intervention during the COVID-19 outbreak had a longer ischemic time (233 [150-375] vs 200 [140-332] minutes, P  94% treated with primary percutaneous coronary intervention in both cohorts). Patients treated with primary percutaneous coronary intervention during the COVID-19 outbreak had a longer ischemic time (233 [150-375] vs 200 [140-332] minutes, P  The number of STEMI patients treated during the current COVID-19 outbreak fell vs the previous year and there was an increase in the median time from symptom onset to reperfusion and a significant 2-fold increase in the rate of in-hospital mortality. No changes in reperfusion strategy were detected, with primary percutaneous coronary intervention performed for the vast majority of patients. The co-existence of STEMI and SARS-CoV-2 infection was relatively infrequent.
YR 2020
FD 2020-10-09
LK https://hdl.handle.net/10668/25791
UL https://hdl.handle.net/10668/25791
LA es
DS RISalud
RD Apr 17, 2025